HomeAbout Investor AwarenessClient ServicesClient Success StoriesManagement TeamClient ProfilesContact Us

Client Profiles

 

CorbusCorbus Pharmaceuticals, Inc.
OTCQB: CRBP
www.corbuspharma.com
Corbus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat life threatening ("orphan") inflammatory-fibrotic diseases with clear unmet needs. The Companyís lead product Resunab is a first- in-class oral anti-inflammatory expected to commence Phase-2a clinical trials for the treatment of cystic fibrosis and scleroderma pending FDA approval of IND.

About Resunab™
Resunab is a novel synthetic oral drug with unique anti-inflammatory and anti-fibrotic activity. Pre-clinical and Phase 1 studies have shown Resunab to have an excellent safety profile in humans and promising potency. Resunab binds to the CB2 receptor of immune cells and triggers a process known as "inflammatory resolution", in effect turning chronic inflammation "off."
Yahoo Data and NewsCompany Web Site

ICON LEGEND
Yahoo Data and News
 Yahoo Finance Data & News
Company Profile Company Profile (PDF)
Company Web Site Company Web Site

News and Updates

Virtual Piggy, Inc. Oink Payments Accelerates Beyond 1 Million Consumers

LOS ANGELES--Virtual Piggy, Inc. (VPIG), provider of innovative safe youth payments technology, Oink, today announced that over 1 million users have signed up for their family wallet solution to shop safely, and securely online.

(full story)

Neurotrope, Inc. Appoints James Gottlieb to the Company's Board of Directors

PLANTATION, Fla., Dec. 16, 2013 -- Neurotrope, Inc. (NTRP) (the "Company") announced today that James Gottlieb has been appointed to the Company's Board of Directors. Mr. Gottlieb has extensive senior level experience in a broad range of positions in Washington, D.C., in the U.S. House and Senate, and in the private and non-profit sectors. During his time in Washington, Mr. Gottlieb directed significant congressional policy and oversight matters regarding the Food and Drug Administration ("FDA") and health-related aspects of the Veterans Administration, the largest civilian health provider in the nation.

(full story)

Virtual Piggy Partners with International Payment Platform Payelp

 

November 14, 2013 Virtual Piggy, Inc. (OTCQB: VPIG), an innovator in safe youth payments, today announced that it has partnered with Payelp Global, bringing its technology to their large network of merchants.

 

 

(full story)

More Articles
 

Upcoming Events

There are no events to display at this time.
Complete Events List
 

CytoDynCytoDyn Inc.
OTC QB: CYDY
www.CytoDyn.com
CytoDyn Inc. is a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, including for the treatment and prevention of Human Immunodeficiency Virus (HIV).

The Company also received the “green light” from the FDA to resume Two Phase 2b with additional Phase 2 studies to start in early 2014.

The Company’s strategy includes Treatment Substitution and potential for Orphan Drug Designation for its antibody. The Company has already begun recruiting for a treatment substitution study that would take patients off their meds, and instead receive a weekly injection of Pro140 for several weeks at a time.  This has the potential to drive groundbreaking advancements for the next generation of HIV treatment. read more
Yahoo Data and NewsCompany Web Site

DumaDuma Energy Corp.
OTC BB: DUMA
www.duma.com
Duma Energy, f/k/a “Strategic American Oil”, is an aggressive growth energy company currently producing oil and natural gas both onshore and offshore in Texas, Louisiana, and Illinois.  The Company seeks accretive acquisitions of production, reserves, or other oil and gas companies that will provide significant growth potential.

The Company recently announced the acquisition of Galveston Bay Energy, which is already providing a meaningful increase in oil production and cash.  The recent Engineering Report from Ralph E. Davis Associates, Inc. estimates net proved reserves of 979,000 barrels of oil and 13 Bcf (billion cubic feet) of natural gas which translates to approximately $75.3 million undiscounted or $54.6 million discounted at 10 percent in net Proved Reserves for Duma Energy.
Yahoo Data and NewsCompany Web Site

Virtual PiggyVirtual Piggy, Inc.
OTC BB: VPIG
www.virtualpiggy.com
Virtual Piggy, Inc. is the first e-commerce solution that enables kids to manage and spend money within parental controls. It enables parents to teach financial management through the use of a secure family wallet that is available online or via mobile and is always 100% free to use. The technology company delivers online security platforms designed for the Under 18 age group in the global online market, and also enables online businesses the ability to function in a manner consistent with the Children’s Online Privacy Protection Act (“COPPA”) and similar international children’s privacy laws. The company is based in Hermosa Beach, CA.
Yahoo Data and NewsCompany Web Site

 

 

lower_banner

lower_banner-02

  Disclaimer     Financial Glossary

©2013 Investor Awareness, Inc. All rights reserved